HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
$CL
$CLOV
$CNC
$CVS
Package Goods/Cosmetics
Consumer Discretionary
Medical Specialities
Health Care
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/18/2024 | $60.00 → $66.00 | Equal Weight → Overweight | Wells Fargo | |
| 11/6/2024 | $247.00 → $308.00 | Underperform → Neutral | BofA Securities | |
| 10/28/2024 | $105.00 → $101.00 | Buy → Hold | Stifel | |
| 10/17/2024 | Buy → Hold | HSBC Securities | ||
| 10/11/2024 | $675.00 | Overweight | KeyBanc Capital Markets | |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | ||
| 10/10/2024 | $63.00 → $82.00 | Equal Weight → Overweight | Barclays | |
| 10/8/2024 | $308.00 | Mkt Perform → Outperform | Bernstein |
CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2024. Third Quarter Highlights Third quarter 2024 net revenues of $118.3 million, a $13.7 million decrease compared to $132.0 million in the prior year period.Third quarter 2024 Submissions were 166,195, a 2.9% increase compared to 161,550 Submissions in the prior year period, with strong contributions from GoHealth's internal captive agents, partially offset by a decline in Submissions from the external GoPartner Solutio
Delivers 9% Total Revenue growth year-to-date compared to prior year period Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year Increases Full-Year 2024 guidance midpoint to target updated range of Adjusted EBITDA profitability of $55 million - $65 million, strongly positioning the Company to invest in membership growth opportunity for 2025 FRANKLIN, Tenn., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today reported financial results for the third quarter 2024. Management will host a co
AUSTIN, Texas, Nov. 6, 2024 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace, today announced its financial results for the third quarter ended September 30, 2024. Please click the PDF link to access the full earnings press release: The earnings press release and earnings presentation can also be accessed on the eHealth Investor Relations website at https://ir.ehealthinsurance.com. Webcast and Conference Call InformationA webcast and conference call will be held today, Wednesday, November 6, 2024 at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time. Individuals interested in listening to the conference call ma
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - eHealth, Inc. (0001333493) (Issuer)
Wells Fargo upgraded CVS Health from Equal Weight to Overweight and set a new price target of $66.00 from $60.00 previously
BofA Securities upgraded Humana from Underperform to Neutral and set a new price target of $308.00 from $247.00 previously
Stifel downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $101.00 from $105.00 previously
CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I., Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE:CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following productive discussions with Glenview Capital Management. "In our discussions with the leadership at Glenview, we agreed that we can deliver greater value from our
Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that it has named Michelle O'Hara as Chief Human Resources Officer, effective January 1, 2025. O'Hara will oversee the enterprise talent strategy and people programs for Humana's more than 63,000 employees. She brings a proven track record of transforming HR capabilities and enabling companies to effectively attract, recruit, develop and retain a talented and diverse workforce. O'Hara will report directly to Humana President and CEO Jim Rechtin. "Humana's people strategy is a core capability for our business that supports and empowers our workforce so they can successfully deliver on our mission to make it easier
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi
8-K - CVS HEALTH Corp (0000064803) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
13F-HR - CVS HEALTH Corp (0000064803) (Filer)
SC 13G/A - Elevation Oncology, Inc. (0001783032) (Subject)
SC 13G/A - Elevation Oncology, Inc. (0001783032) (Subject)
SC 13G/A - Elevation Oncology, Inc. (0001783032) (Subject)
4 - Elevation Oncology, Inc. (0001783032) (Issuer)
4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)
The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso
Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 5 years by 4.56% on an annualized basis producing an average annual return of 17.03%. Currently, UnitedHealth Group has a market capitalization of $515.19 billion. Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 5 years ago, it would be worth $2,205.30 today based on a price of $559.75 for UNH at the time of writing. UnitedHealth Group's Performance Over Last 5 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automa
WOONSOCKET, R.I., Nov. 19, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health. Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company. "Sree and I worked closely together when he started at CVS Health, serving as chief medical officer of CVS Caremark. In that role, and as the leader of Medical Affairs at our company, Sree has served as a trusted advisor to our clients, their members
Colgate-Palmolive (NYSE:CL) Group President, Europe and Developing Markets, Panagiotis Tsourapas and Chief Financial Officer, Stan Sutula, will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on Tuesday, December 3, 2024 at 11:45 a.m. ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center page of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets
eHealth research examines costs & trends midway through Medicare's Annual Enrollment Period and outlines beneficiaries' priorities for President-elect Trump AUSTIN, Texas, Nov. 19, 2024 /PRNewswire/ -- New original research from eHealth, Inc. (NASDAQ:EHTH), a leading online private health insurance marketplace, finds that the average premium for Medicare Part D drug plans selected by beneficiaries in the first half of Medicare's Annual Enrollment Period is up 17% from a year ago. Survey data included in eHealth's report show that 64% of Medicare beneficiaries are more confident in the future sustainability of Medicare based on the outcome of the presidential election. Seventy-two percent (72